3Ohrmann P, Siegmund A, Suslow T, et al. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients : A proton magnetic resonance spectroscopy study [ J]. J Psychiatr Res, 2007,41 ( 8 ) :625 - 634.
4Tanaka Y, Obata T, Sassa T, et al. Quantitative magnetic resonance spectroscopy of schizophrenia: Relationship between decreased N- acetylaspartate and frontal lobe-dysfunction [ J ]. Psychiatry Clin Neurosci, 2006,60 ( 3 ) :365 - 372.
5Tanaka Y,Obata T,Sassa T,et al.Quantitative magnetic resonance spectroscopy of schizophrenia:relationship between decreased N-acetylaspartate and frontal lobe dysfunction.Psychiatry Clin Neurosci,2006,60(3):365-372.
6Ohrmann P,Siegmund A,Suslow T,et al.Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients:a proton magnetic resonance spectroscopy study.J Psychiatr Res,2007,41(8):625-634.
7Shimizu E,Hashimoto K,Ochi S,et al.Posterior cingulate gyrus metabolic changes in chronic schizophrenia with generalized cognitive deficits.J Psychiatr Res,2007,1(1-2):49-56.
8Steen RG,Hamer RM,Lieberman JA.Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia:a systematic review and meta-analysis.Neuropsychopharmacology,2005,30(11):1949-1962.
9Sanches RF,Crippa JA,Hallak JE,et al.Proton magnetic resonance spectroscopy of the frontal lobe in schizophrenics:a critical review of the methodology.Rev Hosp Clin Fac Med Sao Paulo,2004,59(3):145-152.
10Ba(S)so(g)lu C,Cetin M,Oner O,et al.Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients.Turk Psikiyatri Derg,2006,17(2):85-91.
